Insmed, Inc. (INSM) vs Vertex Pharmaceuticals Incorporated (VRTX)
Insmed, Inc. and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $26.8B — 4.9× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Vertex Pharmaceuticals Incorporated trades at 30.4×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 10.2%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs −76.9%) and the higher return on invested capital (24.1% vs −329.2%). Across the 19 metrics below, Vertex Pharmaceuticals Incorporated leads on 16 and Insmed, Inc. on 3.
Valuation
Profitability
| Metric | INSM | VRTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 83.46% | 86.00% | 65.16% |
| Operating margin | (73.89%) | 37.95% | 0.00% |
| Net margin | (76.94%) | 35.00% | 0.00% |
| Free cash flow margin | (71.00%) | 30.16% | 0.00% |
| Return on equity | (87.22%) | 23.54% | (57.72%) |
| Return on assets | (38.20%) | 17.12% | (49.22%) |
| Return on invested capital | (329.22%) | 24.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack